BIOGEN IDEC
BIOGEN IDEC operates in Diversified Metals & Mining.
BIOGEN IDEC (IDP) - Total Liabilities
Latest total liabilities as of September 2024: €11.95 Billion EUR
Based on the latest financial reports, BIOGEN IDEC (IDP) has total liabilities worth €11.95 Billion EUR as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
BIOGEN IDEC - Total Liabilities Trend (2016–2023)
This chart illustrates how BIOGEN IDEC's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
BIOGEN IDEC Competitors by Total Liabilities
The table below lists competitors of BIOGEN IDEC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Antares Metals Ltd
AU:AM5
|
Australia | AU$2.42 Million |
|
Scout Security Ltd
AU:SCT
|
Australia | AU$5.24 Million |
|
Advanced Biomed Inc. Common Stock
NASDAQ:ADVB
|
USA | $1.37 Million |
|
ENZON PHARM (EZ1.SG)
STU:EZ1
|
Germany | €44.62 Million |
|
Dromeas SA
AT:DROME
|
Greece | €37.44 Million |
|
TEXAS INSTRUMENTS - Dusseldorf Stock Exchang
DU:TII
|
Germany | €18.05 Billion |
|
LIGAND PHARMA
BE:LGDN
|
Germany | €113.69 Million |
Liability Composition Analysis (2016–2023)
This chart breaks down BIOGEN IDEC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.73 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.42 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BIOGEN IDEC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BIOGEN IDEC (2016–2023)
The table below shows the annual total liabilities of BIOGEN IDEC from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €12.05 Billion | +7.88% |
| 2022-12-31 | €11.17 Billion | -13.56% |
| 2021-12-31 | €12.92 Billion | -7.29% |
| 2020-12-31 | €13.93 Billion | +0.27% |
| 2019-12-31 | €13.90 Billion | +13.36% |
| 2018-12-31 | €12.26 Billion | +10.88% |
| 2017-12-31 | €11.05 Billion | +2.85% |
| 2016-12-31 | €10.75 Billion | -- |